This inventor holds 4 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents. Top assignee: Genome and Company. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Joo-Yeon Chung: Innovator in Cancer Treatment
Introduction
Joo-Yeon Chung is a prominent inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cancer treatments. His innovative work focuses on enhancing immune responses to combat cancer effectively.
Latest Patents
Joo-Yeon Chung holds a patent for a pharmaceutical composition aimed at preventing or treating cancer. This composition comprises an LRIT2 inhibitor as the active ingredient. The invention is designed to increase the activity of immune cells, serving as an immune enhancer. By enhancing an individual's immunity, the LRIT2 inhibitor can effectively prevent or treat cancer.
Career Highlights
Chung is associated with Genome and Company, where he continues to advance his research in cancer therapies. His work is characterized by a commitment to improving patient outcomes through innovative pharmaceutical solutions.
Collaborations
Some of his notable coworkers include Kyoung Wan Yoon and Youn Kyung Houh. Their collaborative efforts contribute to the ongoing research and development in the field of cancer treatment.
Conclusion
Joo-Yeon Chung's contributions to cancer treatment through his innovative patent highlight the importance of research in pharmaceuticals. His work exemplifies the potential of immune enhancers in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile